Project

A phase III trial evaluating the role of ovarian function suppression and the role of exemestane as adjuvant therapies for premenopausal women with endocrine responsive breast cancer (STP)

Ongoing - recruitment closed · 2009 until 2099

Huober Jens, Demmer-Steingruber Ruth, Quinter Janine